Maria Thomas - Concepedia

Author

Maria Thomas

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology ORCID

Also Known As

A. Suzuki, M Thomas, M. Thomas, Maria THOMAS, Maria Thomas, Thomas, Maria

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology University of Tübingen Heidelberg University University Hospital Heidelberg University Medical Centre Mannheim

About

Maria Thomas is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1K
2	Biochemistry	2	2	46
3	Engineering	1	1	18
4	Health Sciences	1	1	50
5	Natural Sciences	1	1	24

Maria Thomas

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet Jawahar L. Mehta, Nobuhito Sanada, Chang Ping Hu, Circulation Research	2007	438
PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo Kathrin Klein, Maria Thomas, Stefan Winter, Clinical Pharmacology & Therapeutics	2012	150
BMP-9 interferes with liver regeneration and promotes liver fibrosis Katja Breitkopf‐Heinlein, Christoph Meyer, Courtney König, Gut	2017	145
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer Alessandro D. Santin, Stefania Bellone, Eric R. Siegel, American Journal of Obstetrics and Gynecology Cancer EpidemiologyRacial DifferencesMedicineMajor Prognostic IndicatorPathology	2005	144
Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of <i>Clostridium perfringens</i> Enterotoxin Alessandro D. Santin, Stefania Canè, Stefania Bellone, Cancer Research	2005	109
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy Alessandro D. Santin, Fenghuang Zhan, Stefania Canè, British Journal of Cancer Primary UspcNovel Molecular MarkersGeneticsMedicinePathology	2005	108
Comparative analysis of 3D culture methods on human HepG2 cells Claudia Luckert, Christina Schulz, Nadja Lehmann, Archives of Toxicology Regenerative MedicineHuman CellDevelopmental BiologyXenotransplantationCell Division	2016	106
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis S. Swaminathan, Whitney A. High, James F. Ranville, Kidney International Vascular Metal DepositionHeart FailureFibrosisCardiovascular DiseaseMedicine	2008	104
Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained Goran Kungulovski, Suneetha Nunna, Maria Thomas, Epigenetics & Chromatin	2015	94
Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells Maria Thomas, Andreas Geßner, Hans‐Peter Vornlocher, Blood	2005	90

Page 1